Commonwealth Bank’s premium looks vulnerable as credit turns
CR
Cashu Research
Cashu Finance·5 min read
Cashu Research rating
SELL- Target price
- A$110.00
- 12 months
- Price at report
- A$171.14
- as at 2026-11-16
- Current price
- A$172.75
- Implied upside
- -36.3%
TL;DR
- Cashu Research rates CBA SELL with an A$110 12-month target versus A$171.14 at the 16 November 2026 close.
- The valuation rests on 25.7× forward earnings despite 1.4% expected FY27 EPS growth and rising credit stress.
- The view could change if margins beat, impairments stay at 8 basis points, housing stabilises sooner or buybacks support the premium.
Cashu Research rates Commonwealth Bank of Australia (ASX: CBA) SELL with an A$110 price target over 12 months, versus A$171.14 at the ASX close on 16 November 2026, implying a -36% return. The central argument is that the bank’s valuation assumes a level of growth and credit quality that the latest housing and lending data do not support.
A premium without matching growth
CBA trades on 25.7× forward earnings, compared with a ten-year median of about 16.5× and global peers at 15–18×. The report argues that this premium would be difficult to justify even for a bank delivering strong expansion, but consensus FY27 earnings growth is only 1.4%.
FY26 cash profit was A$10.98 billion, up 7%, while return on equity was 14%. The net interest margin fell 3 basis points to 2.05% in FY26, and the September-quarter margin was described as basically stable despite a rising-rate environment. That leaves limited evidence that the valuation is being supported by accelerating profitability.
The earnings comparison is similarly demanding: FY26 cash earnings were A$6.57 a share, against consensus FY27 earnings of A$6.66. The stock is therefore asking investors to pay a high multiple for a business expected to add little per-share earnings growth.
Housing and credit are moving against the stock
Credit indicators have begun to deteriorate. Loan impairment expense rose from 7 basis points of loans in FY25 to 8 basis points in FY26 and 11 basis points annualised in the September quarter. Home-loan arrears of 90 days or more rose to 0.80%, up 7 basis points in one quarter, after increasing 10 basis points in the second half of FY26.
Collective provisions also rose A$105 million in the quarter, mainly because lower house prices affected the mortgage book. The report’s interpretation is that higher rates are beginning to reach household borrowers, rather than the move in credit costs being an isolated quarterly fluctuation.
The mortgage pipeline is weakening. CBA’s home-loan applications were down 16% year on year in the September quarter, while the ABS recorded a 15.5% quarter-on-quarter fall in the value of new housing loans, the largest decline since the series began in 2002. Investor lending fell 32% in the quarter, and owner-occupier loan numbers fell 10% year on year.
CBA’s home-loan book still grew 6.6% over the 12 months to September, or about 1.1 times system growth, because loans written during the boom were still settling. Applications lead settlements by three to six months, so the report expects the slowdown to become more visible in the bank’s loan book from the second half of FY27.
The collateral backdrop is also worsening. National home values were down 6.7% from their March 2026 peak after seven consecutive monthly falls, while CBA’s economists forecast a 14% peak-to-trough decline. The RBA had lifted the cash rate to 4.85% after its fifth hike of the year on 3 November.
Normalisation could do the earnings damage
More than half of CBA’s A$1.08 trillion loan book is made up of home loans, including A$565 billion in retail home lending. That exposure means even a normal credit-cycle deterioration could matter without requiring a financial crisis.
The report estimates that each basis point of impairment on the loan book represents roughly A$110 million of pre-tax earnings. Moving from 8 basis points to 15 basis points would therefore cost about A$750 million before tax, close to 5% of FY26 cash profit. A normal downturn would take impairment costs to 20+ basis points.
The base case uses FY27 cash earnings of A$6.47 a share and a 17× multiple, producing the A$110 target. That multiple is close to CBA’s own ten-year median and remains above the long-run Big Four average of 12.7×, so the valuation does not require an extreme de-rating.
In the bear case, impairments reach 20 basis points, lending growth stalls and margins face modest pressure. FY27 cash earnings fall to about A$5.95 a share, and a 14× multiple produces an implied value of A$83. Even the bull case, which holds consensus earnings and a 21× multiple, produces A$140, still 18% below the price at the time of the report.
What could change the view
The main risk to the SELL thesis is timing. The premium has already survived two years of sell ratings, while super-fund inflows, passive index demand and retail interest can continue supporting the share price regardless of near-term fundamentals. A CET1 ratio of 12% also leaves room for a larger buyback, which could extend the rally.
The next tests are closely defined. The Cotality November home-value index is due on 1 December, the RBA decision is scheduled for 8 December, and December-quarter ABS lending data are expected in early 2027. CBA’s first-half FY27 result in February 2027 will bring arrears, impairment and settlement trends together.
The report identifies three February warning signs: 90-day home-loan arrears above 0.90%, a half-year loan impairment charge above A$600 million, or home-lending growth below system growth. Conversely, the view would need to change if a February margin beat outran the arrears build, impairments held at 8 basis points through the first half of FY27, the housing decline stabilised well short of the 14% forecast, or a buyback was large enough to absorb the de-rating.
The investment case therefore rests less on a sudden collapse than on valuation mean reversion. The report classifies CBA’s business risk as Low but timing risk as High: the franchise may remain resilient while the market gradually stops paying 25.7× earnings for minimal growth.

